Current position:Home >Product >
1-(3,4-diethoxybenzyl)-6,7-diethoxy-2-methyl-1,2-dihydroisoquinoline
1-(3,4-diethoxybenzyl)-6,7-diethoxy-2-methyl-1,2-dihydroisoquinoline(10313-81-2)
- Name: 1-(3,4-diethoxybenzyl)-6,7-diethoxy-2-methyl-1,2-dihydroisoquinoline
- Synonyms:1-(3,4-Diethoxybenzyl)-6,7-diethoxy-2-methylisoquinoliniumiodide (6CI);Isoquinolinium,1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-2-methyl-, iodide (9CI);N-Methylbarboninium iodide (7CI);Barbonine methiodide;NSC 34063;
- Molecular Formula:C25H32 N O4 . I
- Molecular Weight:411.5338
- CAS Registry Number:10313-81-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.10313-81-2 Isoquinolinium,1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxy-2-methyl-, iodide (1:1)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)]
CAS No.10313-81-2 10313-81-2
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]

Other Product
- 28857-09-2/N-(2-{[(E)-{4-[bis(2-chloroethyl)amino]-2-methylphenyl}methylidene]amino}phenyl)-4-methylbenzenesulfonamide
- 5743-24-8/4-{[(methylsulfonyl)(phenyl)amino]methyl}-N-[3-(trifluoromethyl)phenyl]benzamide
- 22202-77-3/GAMFEXINE CITRATE
- 84006-39-3/2-{[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy}-1-methylpropyl hexanoate
- 98601-01-5/(10S,11S)-6-methyl-10,11-dihydrotetraphene-10,11-diol
- 83803-90-1/4-[3-(dimethylamino)propoxy]-2-hydroxybenzophenone
- 58774-06-4/triethyl 3-cyanopentane-1,3,5-tricarboxylate
- 117385-73-6/MvrA protein
- 51688-49-4/3,4-dihydroxymandelonitrile
- 37184-56-8/Benzoic acid,4-amino-,2-(diethylamino)ethyl ester,monohydrochloride,mixt. with Naja venom
- 90064-24-7/Myrrhis odorata, ext.
- 101670-48-8/Hondamycin A (9CI)
- 133734-10-8/Propanedioic acid,mono[(4aS,6aS,8R,9S,11aS,11bS)-tetradecahydro-4,4,9,11b-tetramethyl-9,11a-methano-11aH-cyclohepta[a]naphthalen-8-yl]ester
- 73692-68-9/Hexadecanoic acid, compd. with N,N-dimethyl-1-octadecanamine (1:1)
- 62346-98-9/(4-methylbenzene-1,3-diyl)dimethanediyl diacetate
- 186127-84-4/L-Arginine,N2-[9-[[4-(methoxymethyl)-1-(2-phenylethyl)-4-piperidinyl]phenylamino]-1,9-dioxononyl]-D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-N-cyclohexylglycyl-(9CI)
- 5710-12-3/1-hydroxy-3-propylurea
- 40312-86-5/1,2-di-tert-butyl-2,5-diphenyl-1,2-dihydropyrazine
- 31654-49-6/(2S,2'S,3R)-2'-(3,4-Dihydroxyphenyl)-7'-(β-D-glucopyranosyloxy)-2,2',3,3'-tetrahydro-5,5',7-trihydroxy-2-(4-hydroxyphenyl)-3,8'-bi-(4H-1-benzopyran)-4,4'-dione
- 10313-81-2/1-(3,4-diethoxybenzyl)-6,7-diethoxy-2-methyl-1,2-dihydroisoquinoline
- 43135-99-5/2,2-dimethylpropane-1,3-diyl dihexahydrophthalate
- 85049-73-6/Cobaltate(3-), bis[2-hydroxy-5-nitro-3-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenesulfonato(3-)]-, diethanolamine sodium salts
- 10271-44-0/(3aalpha,4beta,5beta,7beta,7aalpha)-octahydro-4,7-methano-1H-inden-5-ol
- 60048-46-6/N,N’-ETHYLENEBISERUCAMIDE
- 2928-58-7/[2-(4-bromophenyl)-2-oxoethyl](triphenyl)phosphonium
- 6284-12-4/bis(2-methylprop-2-en-1-yl)cyanamide
- 94108-45-9/1-(docos-13-enyl)-5-oxopyrrolidine-3-carboxylic acid
- 7472-37-9/(2Z)-1-(2,4-dinitrophenyl)-2-[phenyl(4-phenylcyclohexyl)methylidene]hydrazine
- 35843-61-9/triphenylstannanylium imidazol-1-ide
- 34328-11-5/Hydrazinecarboximidamide,2-[(4-bromophenyl)[4-(trifluoromethyl)phenyl]methylene]-N,N-dimethyl-,hydrochloride (1:1)